Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4007 Pharmacy

Not Yet Opened 11-14 16:00:00 EST

729.95

-12.32

-1.66%

High742.79	Low729.18	Vol310.79M
Open742.38	D1 Closing742.27	Amplitude1.83%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O11.32B	T/O Rate--	Tradable Shares0.00
P/B5.341469	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"Pharmacy","latestPrice":729.9464,"timestamp":1731617999999,"preClose":742.2688,"halted":0,"volume":310788359,"delay":0,"changeRate":-0.016601,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-12.322388,"latestTime":"11-14 16:00:00 EST","open":742.3848,"high":742.7924,"low":729.17505,"amount":11318796570.882942,"amplitude":0.018346,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1731661200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.341469,"peRate":40.576721,"turnoverRate":0.007502,"increases":44,"decrements":147,"flats":3,"marketCap":3004274424777.25,"floatMarketCap":2808791452036.5},"requestUrl":"/m/hq/s/BK4007/tweets","defaultTab":"tweets","newsList":[{"id":"2483315206","title":"Bristol-Myers Squibb  : HSBC Raises Target Price to $58 From $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2483315206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483315206?lang=en_us&edition=fundamental","pubTime":"2024-11-15 14:33","pubTimestamp":1731652406,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nAZN2MN15G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","BK4581","BK4559","LU1670710661.SGD","LU0985481810.HKD","IE00B2B36J28.USD","LU1571399168.USD","LU1718418525.SGD","LU1585245621.USD","LU0306806265.USD","LU2242652126.USD","IE0002141913.USD","LU0868494617.USD","IE00BJT1NW94.SGD","BK4534","LU0114720955.EUR","BMY","LU1670711123.USD","LU1093756168.USD","LU2125154778.USD","LU1261432733.SGD","LU2360032135.SGD","LU1670711040.USD","LU1989771016.USD","LU0237698245.USD","LU1074936037.SGD","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU2125154935.USD","LU0306807586.USD","BK4588","BK4007","BK4532","LU1670710588.SGD","LU0225284248.USD","LU0321505868.SGD","LU1093756325.SGD","LU1430594728.SGD","LU1032466523.USD","BK4585","LU0225771236.USD","LU2133065610.SGD","LU0882574055.USD","LU0061475181.USD","LU1291159041.SGD","LU0456855351.SGD","IE0009355771.USD","LU2242646821.SGD"],"gpt_icon":0},{"id":"2483901313","title":"Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria","url":"https://stock-news.laohu8.com/highlight/detail?id=2483901313","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483901313?lang=en_us&edition=fundamental","pubTime":"2024-11-15 14:00","pubTimestamp":1731650400,"startTime":"0","endTime":"0","summary":"Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity. More than 300,000 people in the US suffer from chronic spontaneous urticaria  that is inadequately controlled by antihistamines. FDA decision expected by April 18, 2025; if approved, Dupixent would be the first targeted therapy for CSU in a decade. Paris and Tarrytown, NY, November 15, 2024. The US Food and Drug Administration  has accepted for review the resubmission of the supplemental biologics license application  for Dupixent  to treat adults and pediatric patients aged 12 years and older with chronic spontaneous urticaria  whose disease is not adequately controlled with H1 antihistamine treatment. The target action date for the FDA decision is April 18, 2025.Dupixent has been approved for CSU in Japan and the United Arab Emirates  and is also under regulatory review in the EU based on earlier study readouts. Outside of Japan and the UAE, the safety and efficacy of","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OPTreMFV4QxkZ_hb1FVJzw--~B/aD0xNjc7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e521264632e7a9a44e3450108999128","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OPTreMFV4QxkZ_hb1FVJzw--~B/aD0xNjc7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e521264632e7a9a44e3450108999128"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-dupixent-sbla-accepted-060000634.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["UAE","LU1974910355.USD","LU2362541273.HKD","LU0053666078.USD","LU0320765992.SGD","IE00BFXG1179.USD","LU0882574055.USD","LU2089984988.USD","REGN","LU0889565916.HKD","LU0823416689.USD","BK4588","SNY","LU2106854487.HKD","LU0114720955.EUR","LU2023250504.SGD","LU0289739699.SGD","LU2468319806.SGD","BK4585","LU0058720904.USD","BK4139","LU0109394709.USD","LU2362541513.USD","LU2362540622.SGD","LU1917777945.USD","BK4007"],"gpt_icon":1},{"id":"2483562313","title":"Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483562313","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483562313?lang=en_us&edition=fundamental","pubTime":"2024-11-15 13:59","pubTimestamp":1731650340,"startTime":"0","endTime":"0","summary":"Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by antih","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/15/2981762/0/en/Dupixent-dupilumab-sBLA-Accepted-for-FDA-Review-for-the-Treatment-of-Chronic-Spontaneous-Urticaria-CSU.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG1179.USD","LU0320765992.SGD","LU2106854487.HKD","REGN","LU1974910355.USD","BK4585","LU0114720955.EUR","LU0053666078.USD","LU1917777945.USD","LU2089984988.USD","LU0058720904.USD","BK4139","LU2362541513.USD","LU2023250504.SGD","LU0823416689.USD","LU0882574055.USD","BK4007","LU2362541273.HKD","BK4588","LU0289739699.SGD","SNY","LU2468319806.SGD","UAE","LU0889565916.HKD","LU0109394709.USD","LU2362540622.SGD"],"gpt_icon":1},{"id":"2483318455","title":"PRESS DIGEST - Wall Street Journal - Nov 15","url":"https://stock-news.laohu8.com/highlight/detail?id=2483318455","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483318455?lang=en_us&edition=fundamental","pubTime":"2024-11-15 13:55","pubTimestamp":1731650147,"startTime":"0","endTime":"0","summary":"Nov 15 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.    - Warren Buffett's Berkshire Hathaway ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B775SV38.USD","POOL","SG9999017495.SGD","SG9999013999.USD","DPZ","LU2602419157.SGD","SG9999014914.USD","LU0708995401.HKD","IE00BK4W5L77.USD","BK4550","LU1366192091.USD","LU1868836757.USD","BK4534","SG9999018865.SGD","BK4588","LU0106261372.USD","BRK.B","LU2491050154.USD","SG9999014880.SGD","LU2491049909.HKD","SGXZ51526630.SGD","IE00B3S45H60.SGD","LU0203202063.USD","LU2106854487.HKD","SG9999015986.USD","LU0154236417.USD","LU1057294990.SGD","LU1804176565.USD","LU1623119135.USD","BK4007","LU0466842654.USD","LU1127390331.HKD","LU1280957306.USD","IE0004445239.USD","IE00BJLML261.HKD","LLY","LU0820561909.HKD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU1093756168.USD","LU0256863811.USD","LU2237443382.USD","LU1914381329.SGD","LU0385154629.USD","LU1551013425.SGD","LU2237438978.USD","LU0203201768.USD","SG9999015945.SGD","BK4567"],"gpt_icon":1},{"id":"2483330705","title":"Vaccine Stocks Slide After Trump Nominates Robert F. Kennedy Jr. to Be Top Health Official","url":"https://stock-news.laohu8.com/highlight/detail?id=2483330705","media":"Yahoo Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483330705?lang=en_us&edition=fundamental","pubTime":"2024-11-15 13:40","pubTimestamp":1731649200,"startTime":"0","endTime":"0","summary":"Vaccine stocks slipped on Thursday after multiple reports indicated President-elect Donald Trump would name anti-vaccine activist Robert F. Kennedy Jr. to lead the Department of Health and Human Servi","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_sg","url":"https://finance.yahoo.com/news/moderna-novovax-stocks-slide-after-trump-nominates-robert-f-kennedy-jr-to-be-top-health-official-212802309.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":"8b50228a679c44f870e44bbf889089f6","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/moderna-novovax-stocks-slide-after-trump-nominates-robert-f-kennedy-jr-to-be-top-health-official-212802309.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_sg","symbols":["BK4588","SNY","LU1057294990.SGD","SG9999002232.USD","SG9999011175.SGD","BK4548","LU0225771236.USD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU0306806265.USD","BK4534","LLY","LU1023059063.AUD","GSK","SG9999003800.SGD","LU1894683264.USD","LU0306807586.USD","BK4007","MRNA","BK4532","BK4581","LU0985481810.HKD","LU0225284248.USD","LU1883839398.USD","BK4585","BK4568","BK4550","BK4501","LU0321505439.SGD","LU0122379950.USD","IE00B19Z3581.USD","PFE","BK4547","SG9999002224.SGD","LU0234572021.USD","LU0170899867.USD","BK4592","SG9999001176.USD","SGXZ57979304.SGD","LU1066051498.USD","BK4533","IE00BBT3K403.USD","IE00BLSP4239.USD","BNTX","LU0456855351.SGD","NVAX","NVO","IE0002270589.USD","LU0321505868.SGD","LU0058720904.USD","LU1066053197.SGD","AMGN","REGN","SG9999001176.SGD","LU0289739699.SGD","BK4551","IE00B19Z3B42.SGD"],"gpt_icon":1},{"id":"2483339242","title":"Lilly sues US agency over blocking of drug-rebate program","url":"https://stock-news.laohu8.com/highlight/detail?id=2483339242","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483339242?lang=en_us&edition=fundamental","pubTime":"2024-11-15 13:01","pubTimestamp":1731646888,"startTime":"0","endTime":"0","summary":"Nov 14 (Reuters) - Eli Lilly    said on Thursday it sued the federal Health Resources and Services Administration (HRSA) over allegedly blocking the company's plan to change the way it offers drug dis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","GB00BDT5M118.USD","LU2265009873.SGD","LU1623119135.USD","LU1127390331.HKD","LU0889566641.SGD","IE000M9KFDE8.USD","LU1778281490.HKD","LU2324357040.USD","LU0882574139.USD","LU2237443622.USD","SG9999015945.SGD","LU0234572021.USD","LU1917777945.USD","BK4534","LU0061475181.USD","LU1261432733.SGD","LU2491049909.HKD","SGXZ57979304.SGD","LU0320765059.SGD","LU2089984988.USD","LU0203202063.USD","JNJ","LU1244550494.USD","LU1244550577.SGD","LU0354030438.USD","LLY","LU2106854487.HKD","LU0106261372.USD","LU2264538146.SGD","BK4007","LU0098860793.USD","LU0320765646.SGD","LU1035775433.USD","LU1983299246.USD","SG9999002232.USD","LU1196500208.SGD","LU1221951129.SGD","LU1551013425.SGD","SG9999015952.SGD","LU1069344957.HKD","BK4550","LU0079474960.USD","LU0203345920.USD","LU1974910355.USD","LU2361044865.SGD","SG9999014880.SGD","LU1551013342.USD","LU2063271972.USD","LU2237443895.HKD"],"gpt_icon":1},{"id":"2483391271","title":"NovaBay Pharmaceuticals Reports Q3 2024 Financials Amid Strategic Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2483391271","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483391271?lang=en_us&edition=fundamental","pubTime":"2024-11-15 12:22","pubTimestamp":1731644541,"startTime":"0","endTime":"0","summary":"Novabay Pharmaceuticals ( ($NBY) ) has released its Q3 earnings. Here is a breakdown of the information Novabay Pharmaceuticals presented to its in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novabay-pharmaceuticals-reports-q3-2024-financials-amid-strategic-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novabay-pharmaceuticals-reports-q3-2024-financials-amid-strategic-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NBY"],"gpt_icon":0},{"id":"2483939121","title":"Sembcorp Industries Subsidiary Completes 30% Stake Acquisition in Senoko Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2483939121","media":"MT Newswires","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483939121?lang=en_us&edition=fundamental","pubTime":"2024-11-15 12:18","pubTimestamp":1731644284,"startTime":"0","endTime":"0","summary":"Sembcorp Industries'  wholly owned subsidiary, Sembcorp Utilities, completed the acquisition of a 30% stake in Senoko Energy for an equity consideration of SG$96 million, according to a filing with the Singapore Exchange on Friday.Senoko Energy, which has about 2.6 GW of registered power generation capacity, is now an associated company of Sembcorp.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6113","IE00BYTNYN87.SGD","SG9999004360.SGD","SGXZ27511609.SGD","SG9999006266.SGD","BK6500","SG9999014492.USD","IE00B12V2V27.USD","BK4007","IE00BYQNZ168.SGD","SG9999003826.SGD","SG9999001135.SGD","SG9999008742.SGD","SG9999011746.SGD","SG9999014484.SGD","U96.SI","SG9999001226.SGD","SG9999000475.SGD"],"gpt_icon":0},{"id":"2483268399","title":"Ocular Therapeutix Reports Q3 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2483268399","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483268399?lang=en_us&edition=fundamental","pubTime":"2024-11-15 11:59","pubTimestamp":1731643158,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix Inc ( ($OCUL) ) has released its Q3 earnings. Here is a breakdown of the information Ocular Therapeutix Inc presented to its inv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ocular-therapeutix-reports-q3-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ocular-therapeutix-reports-q3-2024-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2483578399","title":"SNDL Announces Renewal of Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2483578399","media":"THOMSON REUTERS","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483578399?lang=en_us&edition=fundamental","pubTime":"2024-11-15 11:55","pubTimestamp":1731642932,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nTUAC4GVT7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4007","BK4547","SNDL"],"gpt_icon":0},{"id":"2483541318","title":"SNDL Announces Renewal of Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2483541318","media":"PR Newswire","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483541318?lang=en_us&edition=fundamental","pubTime":"2024-11-15 11:55","pubTimestamp":1731642900,"startTime":"0","endTime":"0","summary":"CALGARY, AB, Nov. 14, 2024 /PRNewswire/ - SNDL Inc.   announced today that its board of directors  has approved the renewal of its share repurchase program  upon the expiry of its current share repurchase program on November20, 2024. The Share Repurchase Program authorizes the Company to repurchase up to C$100million  of its outstanding common shares  from time to time at prevailing market prices, enabling SNDL to opportunistically return valueto shareholders.Pursuant to the Share Repurchase Program, SNDL may purchase shares from time to time at the discretion of management through open market purchases, privately negotiated transactions, block trades, derivatives, accelerated or other structured share repurchase programs, or other means.The manner, timing, pricing and amount of any transactions will be subject to the discretion of SNDL and may be based upon market conditions, regulatory requirements and alternative opportunities that SNDL may have for the use or investment of its capi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AjVgd87rgokTnzg4_Xx3rw--~B/aD0yMDc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/dcd6665939ebc7677beed1ce404d17d1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AjVgd87rgokTnzg4_Xx3rw--~B/aD0yMDc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/dcd6665939ebc7677beed1ce404d17d1"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/sndl-announces-renewal-share-repurchase-035500808.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sndl-announces-renewal-share-repurchase-035500808.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SNDL","BK4007","BK4557","BK4547"],"gpt_icon":0},{"id":"2483639888","title":"Cann Group Ltd. Issues Unquoted Equity Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2483639888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483639888?lang=en_us&edition=fundamental","pubTime":"2024-11-15 10:32","pubTimestamp":1731637956,"startTime":"0","endTime":"0","summary":"Cann Group Ltd. (AU:CAN) has released an update. Cann Group Ltd. has announced the issuance of a series of unquoted equity securities under an empl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cann-group-ltd-issues-unquoted-equity-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cann-group-ltd-issues-unquoted-equity-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQR","BK4595","BK4215","BK4526","BK4007","BK4170","BK4585","BK4588","CAN","CNGGF"],"gpt_icon":0},{"id":"2483336742","title":"Cann Group Ltd. Issues New Equity Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2483336742","media":"TIPRANKS","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483336742?lang=en_us&edition=fundamental","pubTime":"2024-11-15 10:22","pubTimestamp":1731637346,"startTime":"0","endTime":"0","summary":"Cann Group Ltd. (AU:CAN) has released an update. Cann Group Ltd. has announced the issuance of 1.2 million new options set to expire in October 202...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cann-group-ltd-issues-new-equity-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cann-group-ltd-issues-new-equity-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4595","BK4588","BK4170","CNGGF","BK4585","CAN","BK4007","BK4526","BK4215","EQR"],"gpt_icon":0},{"id":"2483436372","title":"Refined Energy Corp. Extends Warrant Expiry Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2483436372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483436372?lang=en_us&edition=fundamental","pubTime":"2024-11-15 08:37","pubTimestamp":1731631059,"startTime":"0","endTime":"0","summary":"Refined Metals (TSE:RUU) has released an update. Refined Energy Corp. is extending the expiry date of over 2.5 million common share purchase warran...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/refined-energy-corp-extends-warrant-expiry-date?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/refined-energy-corp-extends-warrant-expiry-date?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RFMCF","BK4007","BK4168"],"gpt_icon":0},{"id":"2483835099","title":"TFF Pharmaceuticals Shares Fall 66%; Company to Wind Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2483835099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483835099?lang=en_us&edition=fundamental","pubTime":"2024-11-15 08:01","pubTimestamp":1731628860,"startTime":"0","endTime":"0","summary":"TFF Pharmaceuticals shares dropped after the company said it terminated its employees and will wind down operations.The stock slid 66%, to 55 cents, in after-hours trading Thursday.The company previously warned in financial filings that there was substantial doubt about its ability to continue operating as a going concern.TFF said in September that it would work with Emory University and the Biomedical Advanced Research and Development Authority on potential use of the company's Thin Film Freezing technology for inhalational delivery of antiviral therapy against respiratory viruses.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TFFP"],"gpt_icon":0},{"id":"2483576353","title":"Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2483576353","media":"reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483576353?lang=en_us&edition=fundamental","pubTime":"2024-11-15 07:43","pubTimestamp":1731627782,"startTime":"0","endTime":"0","summary":"Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer drug NEW YORK, Nov 14 (Reuters) - Bristol Myers Squibb BMY.N was hit on Thursday with a $6.7 billion lawsuit claiming it cheated forme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL1N3ML1FU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU0114720955.EUR","LU0882574055.USD","LU1261432733.SGD","LU1670710588.SGD","LU1670711123.USD","BMY","LU1032466523.USD","BK4581","LU1718418525.SGD","LU0456855351.SGD","UMBF","LU1670711040.USD","LU2133065610.SGD","LU1989771016.USD","LU1430594728.SGD","LU2125154935.USD","BK4211","LU1093756168.USD","IE0002141913.USD","LU2242652126.USD","LU0306806265.USD","BK4007","LU0237698245.USD","LU2242646821.SGD","LU2360032135.SGD","LU0061475181.USD","LU2125154778.USD","BK4534","LU1585245621.USD","BK4559","LU0321505868.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0225771236.USD","LU1670710661.SGD","IE00B2B36J28.USD","BK4585","LU1093756325.SGD","LU1074936037.SGD","LU0225284248.USD","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU0868494617.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU1291159041.SGD","IE00BSNM7G36.USD","LU0985481810.HKD","BK4588"],"gpt_icon":0},{"id":"2483316352","title":"InMed Pharmaceuticals Makes Progress on Alzheimer’s Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2483316352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483316352?lang=en_us&edition=fundamental","pubTime":"2024-11-15 07:08","pubTimestamp":1731625701,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals (INM) has released an update. InMed Pharmaceuticals has made significant strides in its pharmaceutical programs, particularly...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inmed-pharmaceuticals-makes-progress-on-alzheimers-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inmed-pharmaceuticals-makes-progress-on-alzheimers-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU2065732104.USD","BK4097","PRGS","INM"],"gpt_icon":0},{"id":"2483354680","title":"Howard Marks Adjusts Portfolio, Major Moves in TORM PLC and Talen Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2483354680","media":"GuruFocus.com","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483354680?lang=en_us&edition=fundamental","pubTime":"2024-11-15 07:01","pubTimestamp":1731625268,"startTime":"0","endTime":"0","summary":"Insights from Oaktree Capital's Latest 13F Filing for Q3 2024. Howard Marks , the chairman of Oaktree Capital Management LP, has made significant adjustments to his investment portfolio in the third quarter of 2024. Oaktree, known for its focus on alternative investments and less efficient markets, primarily invests in debt, preferred stocks, and convertible bonds. Marks is renowned for his adherence to a core investment philosophy that emphasizes deep understanding of market structures and client communication.Talen Energy Corp , purchasing 696,676 shares, which now represent 2.24% of the portfolio, valued at approximately $124.18 million.California Resources Corp , with 2,046,753 shares, making up about 1.94% of the portfolio, valued at roughly $107.39 million.Indivior PLC , adding 5,028,807 shares, bringing the total to 9,521,980 shares. This adjustment marks a 111.92% increase in share count, impacting the portfolio by 0.89%, with a total value of $94.07 million.This article, gener","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/T1tipwEhqdTSVrtTiDNNew--~B/aD05MDI7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/647175e2e436056ebba068f9aa8b3f50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/T1tipwEhqdTSVrtTiDNNew--~B/aD05MDI7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/647175e2e436056ebba068f9aa8b3f50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/howard-marks-adjusts-portfolio-major-230108210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4526","LU0823426480.USD","BK4089","LU1051768304.USD","SBLK","LU2008162690.USD","TLN","LU1023057109.AUD","PSQ","YUMC","LBTYA","STR","LU0456854461.SGD","LU0348825331.USD","QLD","LBTYB","LU0359202008.SGD","GTX","EXE","LBYAV","LU0594300419.USD","QID","LU0650527681.SGD","CRC","LBTYK","BK4105","BK4007","HBMD","LU0228659784.USD","OACB.U","BK4144","BK4020","LBYKV","INDV","IE0031619046.USD","TRMD","SQQQ","IE00B19Z4B17.USD","LU0359201612.USD","IE00B0JY6N72.USD","LU0456842615.SGD","LU2065169927.USD","TORM","TQQQ",".IXIC","INFN","BK4211","NQmain","LU2065171311.SGD","LU2065171402.SGD","MNQmain"],"gpt_icon":1},{"id":"2483354395","title":"Robert Bruce's Strategic Moves in Q3 2024: Spotlight on AerCap Holdings NV","url":"https://stock-news.laohu8.com/highlight/detail?id=2483354395","media":"GuruFocus.com","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483354395?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:56","pubTimestamp":1731624986,"startTime":"0","endTime":"0","summary":"Robert Bruce , the seasoned investor behind Bruce & Co, has made notable adjustments to his investment portfolio in the third quarter of 2024, as revealed in the latest 13F filing. Bruce & Co, which advises the Bruce Fund , is known for its focus on common stocks, high-yield and distressed debt, with occasional investments in long-term U.S. government securities. The firm, led by Robert Bruce  and his son, Robert Jeffrey Bruce, primarily targets small- and mid-cap stocks but does not shy away from large-cap, convertible, and distressed bonds. Their investment philosophy centers on acquiring distressed companies at a discount, aiming for a significant turnaround.GuruFocus has detected 7 Warning Signs with UHAL.B.The standout addition was AerCap Holdings NV , with 80,000 shares, representing 2.21% of the portfolio, valued at $7.58 million.Bunge Global SA  experienced a 60% increase in shares, with an additional 30,000 shares bringing the total to 80,000, valued at $7.73 million.This arti","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PrjcvQ9d9RJXBds12nKhNA--~B/aD05MDI7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/6ba4e4c461601cc4a7cdb761cbc5f3df","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PrjcvQ9d9RJXBds12nKhNA--~B/aD05MDI7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/6ba4e4c461601cc4a7cdb761cbc5f3df"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/robert-bruces-strategic-moves-q3-225626375.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1119994496.HKD","LU1989772840.SGD","LU2237443895.HKD","BK4534","ADM","IE00B29SXK94.USD","IE00BMG7P694.USD","LU0198837287.USD","IE00B4R5TH58.HKD","BG","LU0312595415.SGD","LU1699723380.USD","IE00BFTCPJ56.SGD","LU1244550221.USD","LU1974910355.USD","NEE","LU1003077747.HKD","MRK","BK4007","LU2244417387.USD","IE00BBT3K403.USD","LU0114720955.EUR","IE00B3CCJ633.GBP","ABBV","LU1732799900.SGD","LU0689626769.HKD","LU2211814178.USD","LU1162221912.USD","LU1496350171.SGD","LU0943347566.SGD","LU0786609619.USD","AER","SG9999014567.USD","LU0203345920.USD","LU0265550946.USD","UHAL","LU0965509283.SGD","LU1261432733.SGD","LU0109981661.USD","ALL","LU0795875086.SGD","UHAL.B","BK4585","IE00BMG7P587.USD","SG9999015952.SGD","IE00BMG7P702.HKD","LU1941712264.USD","LU1093756325.SGD","LU2361045086.USD","IE00BVYPNW00.USD"],"gpt_icon":0},{"id":"2483597103","title":"BUZZ-Vaccine makers, packaged food cos slide as Trump taps RFK to head health agency","url":"https://stock-news.laohu8.com/highlight/detail?id=2483597103","media":"reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483597103?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:41","pubTimestamp":1731624107,"startTime":"0","endTime":"0","summary":"BUZZ-Vaccine makers, packaged food cos slide as Trump taps RFK to head health agency** Shares of vaccine makers tumbled at the end of Thursday's trading session as U.S. President-elect Donald Trump selected Robert F Kennedy Jr to head the Department of Health and Human Services** BioNTech BNTX.O, Moderna MRNA.O, Pfizer PFE.N, GSK GSK.N and Sanofi SNY.O ended down between 2.1% and 7.1%** Kennedy has made false medical claims, including that vaccines are linked to autism ** In after hours trading, the share price movement among the drugmakers was more muted** Kennedy has also vowed to reduce the dominance of ultra-processed foods; shares of Sysco SYY.N dropped 2% for the day and Kraft Heinz KHC.O> fell 1%, while PepsiCo PEP.O pared earlier to end up 0.2%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL1N3ML1DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY","KHC","LU0238689110.USD","LU0058720904.USD","BK5011","LU1934455277.USD","LU0109981661.USD","LU1015430645.USD","IE00BFXG1179.USD","PFE","GSK.UK","IE00BBT3K403.USD","SG9999002224.SGD","BNTX","SG9999001440.SGD","LU0208291251.USD","LU0203345920.USD","LU1093756168.USD","LU2324357040.USD","LU2023250504.SGD","SG9999013999.USD","BK4588","LU1487256676.USD","LU0985481810.HKD","BK4532","SYY","LU1061106388.HKD","LU0006061336.USD","LU1046248800.SGD","LU1066051225.USD","MRK","BK4007","IE00B3T34201.USD","LU1481600234.SGD","LU0006306889.USD","MRNA","LU0106261372.USD","LU0575583348.USD","LU0321505868.SGD","LU1645745479.HKD","BK4533","LU0211331839.USD","LU2023250843.SGD","SG9999002232.USD","IE00BSNM7G36.USD","LU0965508806.USD","LU1894683264.USD","LU1983299246.USD","LU2468319806.SGD","PEP"],"gpt_icon":1}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4007","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmacy,BK4007,Pharmacy股票,Pharmacy股票老虎,Pharmacy股票老虎国际,Pharmacy行情,Pharmacy股票行情,Pharmacy股价,Pharmacy股市,Pharmacy股票价格,Pharmacy股票交易,Pharmacy股票购买,Pharmacy股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}